Dual effects of vitamin D-induced alteration of TH1/TH2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease.

[1]  T. Meehan,et al.  CD8+ T cells are not necessary for 1α,25-dihydroxyvitamin D3 to suppress experimental autoimmune encephalomyelitis in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  P. Matricardi,et al.  Prevalence of atopy and asthma in eastern versus western Europe: why the difference? , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[3]  D. Strachan,et al.  Asthma and allergy in Albania and the UK , 2001, The Lancet.

[4]  T. Shimoda,et al.  Correlation between airway hyperresponsiveness and airway inflammation in a young adult population: eosinophil, ECP, and cytokine levels in induced sputum. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[5]  L. Adorini,et al.  Induction of transplantation tolerance by 1,25-dihydroxyvitamin D(3). , 2001, Transplantation proceedings.

[6]  R. Geha,et al.  Glucocorticoids upregulate CD40 ligand expression and induce CD40L-dependent immunoglobulin isotype switching. , 2001, The Journal of clinical investigation.

[7]  D. Leung,et al.  Additive immunosuppressive effects of 1,25-dihydroxyvitamin D3 and corticosteroids on TH1, but not TH2, responses. , 2000, The Journal of allergy and clinical immunology.

[8]  M. Cantorna,et al.  1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. , 2000, The Journal of nutrition.

[9]  P. Bruijnzeel,et al.  Therapeutic interventions in mice with chronic proliferative dermatitis (cpdm/cpdm) , 2000, Experimental dermatology.

[10]  A. Seaton,et al.  Diet and childhood asthma in a society in transition: a study in urban and rural Saudi Arabia , 2000, Thorax.

[11]  C. Mathieu,et al.  1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). , 2000, Diabetes.

[12]  H. DeLuca,et al.  In vivo upregulation of interleukin-4 is one mechanism underlying the immunoregulatory effects of 1,25-dihydroxyvitamin D(3). , 2000, Archives of biochemistry and biophysics.

[13]  S. Goldstein,et al.  Effects of long-term administration of vitamin D3 analogs to mice. , 2000, The Journal of endocrinology.

[14]  H. DeLuca,et al.  Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. , 2000, Archives of biochemistry and biophysics.

[15]  G. Martino,et al.  Inhibition of Th1 development and treatment of chronic‐relapsing experimental allergic encephalomyelitis by a non‐hypercalcemic analogue of 1,25‐dihydroxyvitamin D3 , 2000, European journal of immunology.

[16]  R. Djukanović,et al.  The relationship between airways inflammation and asthma severity. , 2000, American journal of respiratory and critical care medicine.

[17]  S. Holgate.  The epidemic of allergy and asthma , 1999, Nature.

[18]  Steerenberg,et al.  Environmental and lifestyle factors may act in concert to increase the prevalence of respiratory allergy including asthma , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[19]  O. Kaminuma,et al.  Transcriptional control of the IL-5 gene by human helper T cells: IL-5 synthesis is regulated independently from IL-2 or IL-4 synthesis. , 1999, The Journal of allergy and clinical immunology.

[20]  D. H. Zhang,et al.  Differential responsiveness of the IL-5 and IL-4 genes to transcription factor GATA-3. , 1998, Journal of immunology.

[21]  H. DeLuca,et al.  1,25-Dihydroxyvitamin D3 prolongs graft survival without compromising host resistance to infection or bone mineral density. , 1998, Transplantation.

[22]  M. Jordana,et al.  Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia. , 1998, The Journal of clinical investigation.

[23]  H. DeLuca,et al.  1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. , 1998, Journal of immunology.

[24]  C. Mathieu,et al.  Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine. , 1998, Transplantation.

[25]  H. DeLuca,et al.  1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. , 1998, The Journal of nutrition.

[26]  M. Cippitelli,et al.  Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. , 1998, The Journal of clinical investigation.

[27]  C. Mathieu,et al.  Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A. , 1998, Endocrinology.

[28]  R. Coffman,et al.  CD40 signaling induces interleukin‐4‐independent IgE switching in vivo , 1996, European journal of immunology.

[29]  R. Coffman,et al.  Interleukin (IL)-4-independent immunoglobulin class switch to immunoglobulin (Ig)E in the mouse , 1996, The Journal of experimental medicine.

[30]  H. DeLuca,et al.  1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Broide,et al.  Compartmentalization of eosinophil granulocyte-macrophage colony-stimulating factor expression in patients with asthma. , 1996, The Journal of allergy and clinical immunology.

[32]  H. Kita,et al.  Eosinophils in allergy: role in disease, degranulation, and cytokines. , 1996, International archives of allergy and immunology.

[33]  H. Spiegelberg,et al.  Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. , 1995, The Journal of nutrition.

[34]  S. de Vos,et al.  Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels. , 1995, Leukemia research.

[35]  C. Mathieu,et al.  Potential role of 1,25(OH)2 vitamin D3 as a dose-reducing agent for cyclosporine and FK 506. , 1994, Transplantation proceedings.

[36]  R. Pauwels,et al.  Attenuation of allergic airway inflammation in IL‐4 deficient mice , 1994, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[37]  R. Egan,et al.  Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. , 1993, The American review of respiratory disease.

[38]  H. DeLuca,et al.  1α,25-dihydroxyvitamin D3 a nd 19-nor-1α,25-dihydroxyvitamin 32 suppress immunoglobulin production and thymic lymphocyte proliferation in vivo , 1993 .

[39]  R. Bouillon,et al.  1,25-Dihydroxyvitamin D3 Prevents Insulitis in NOD Mice , 1992, Diabetes.

[40]  J. Adams,et al.  1,25‐Dihydroxyvitamin D3 inhibits the passive transfer of cellular immunity by a myelin basic protein‐specific T cell clone , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[41]  J M Lemire,et al.  1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. , 1991, The Journal of clinical investigation.

[42]  J. Bousquet,et al.  Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.

[43]  H. Koeffler,et al.  1,25-Dihydroxy-16-ene-23-yne-vitamin D3 prolongs survival time of leukemic mice. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[44]  A. Tobler,et al.  1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Adams,et al.  1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. , 1985, Journal of immunology.

[46]  S. Iho,et al.  The role of monocytes in the suppression of PHA-induced proliferation and IL 2 production of human mononuclear cells by 1,25-dihydroxyvitamin D3. , 1985, Immunology letters.

[47]  J. Adams,et al.  1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. , 1984, The Journal of clinical investigation.